Clinical Trials Logo
  1. Home
  2. Insomnia Disorder
  3. NCT03885141

Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder. — ZOLP_18_01  

Insomnia Disorder Clinical Trial

Official title:
Phase II / III Study, One Center, Double-Blind, With Placebo Use, in Parallel Groups to Assess the Efficacy and Safety of Zolpidem® Orodispersible in Adult Subjects (Females and Males) in the Treatment of Maintenance Insomnia Disorder.

Clinical Trial Summary

Biolab Sanus is developing a product in the form of orodispersible tablet containing 1.0 mg, 1.75 mg and 3.5 mg of Zolpidem®. Thus, it is intended to evaluate the efficacy of Zolpidem® Orodispersible 1.0 mg or 1.75 mg in women and Zolpidem Orodispersible 1.75 mg or 3.5 mg in men for the improvement of the maintenance insomnia disorder, through the evaluation of the Insomnia Severity Index, and using a Sleep Diary throughout the study, as well as to evaluate the latency of the sleep after a spontaneous or provoked wake up measured by polysomnography.

Clinical Trial Description

Information provided evidence for the therapeutic use of Zolpidem® in the treatment of insomnia. Several studies have emphasized the importance of using Zolpidem® in small doses, in the orodispersible form, in the treatment of insomnia. Accordingly, Biolab Sanus is developing a product in the form of orodispersible tablet containing 1.0 mg, 1.75 mg and 3.5 mg of Zolpidem®. Thus, it is intended to evaluate the efficacy of Zolpidem® Orodispersible 1.0 mg or 1.75 mg in women and Zolpidem Orodispersible 1.75 mg or 3.5 mg in men for the improvement of the maintenance insomnia disorder, through the evaluation of the Insomnia Severity Index, and using a Sleep Diary throughout the study, as well as to evaluate the latency of the sleep after a spontaneous or provoked wake up measured by polysomnography. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03885141
Study type Interventional
Source Biolab Sanus Farmaceutica
Contact Luciano R Pinto Junior, PhD
Phone 55.11.973342037
Email lucianoribeiro48@gmail.com
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date March 2021
Completion date December 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT00821041 - Internet-based Treatment for Chronic Insomnia Phase 2
Completed NCT03727438 - Provider Supported Self-Help Cognitive Behavioral Therapy for Insomnia (Tele-Self CBTI) N/A
Recruiting NCT03633305 - Optimization of Insomnia Treatment in Primary Care N/A
Completed NCT04616157 - Internet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility Trial N/A
Completed NCT03679884 - Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep Phase 3
Completed NCT02839200 - Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder Phase 2
Recruiting NCT04752254 - Investigating Racing Thoughts in Patients With Insomnia Disorder
Completed NCT05541055 - Digital CBT-I for Insomnia Disorder N/A
Completed NCT05558865 - Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia) N/A
Active, not recruiting NCT06393504 - Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
Completed NCT02841709 - Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder Phase 2
Completed NCT03328585 - Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis N/A
Completed NCT02952820 - Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) Phase 3
Recruiting NCT05408078 - Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders N/A
Recruiting NCT05780983 - Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults N/A
Completed NCT03575104 - Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep Phase 3
Not yet recruiting NCT06279286 - Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder Phase 1/Phase 2
Terminated NCT02571595 - A Sleep Program to Improve Sleep Quality in People With HIV N/A
Completed NCT00984698 - A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD) N/A
Recruiting NCT05780177 - Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder N/A